BMO Capital Maintains Outperform on Horizon Therapeutics, Raises Price Target to $46
BMO Capital maintains Horizon Therapeutics (NASDAQ:HZNP) with a Outperform and raises the price target from $40 to $46.
Baird Maintains Outperform on Mastercard, Raises Price Target to $348
Baird maintains Mastercard (NYSE:MA) with a Outperform and raises the price target from $338 to $348.
Baird Maintains Neutral on Eaton, Raises Price Target to $101
Baird maintains Eaton (NYSE:ETN) with a Neutral and raises the price target from $93 to $101.
BMO Capital Maintains Outperform on B2Gold, Raises Price Target to $7.25
BMO Capital maintains B2Gold (TSX:BTO) with a Outperform and raises the price target from $7 to $7.25.
Baird Maintains Outperform on EOG Resources, Raises Price Target to $92
Baird maintains EOG Resources (NYSE:EOG) with a Outperform and raises the price target from $89 to $92.
Nomura Maintains Buy on Deciphera Pharmaceuticals, Raises Price Target to $84
Nomura maintains Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy and raises the price target from $57 to $84.
Nomura Maintains Neutral on Capital One Financial, Raises Price Target to $111
Nomura maintains Capital One Financial (NYSE:COF) with a Neutral and raises the price target from $108 to $111.
Stocks That Hit 52-Week Highs On Wednesday
During the morning session on Wednesday, 398 stocks hit new 52-week highs. Interesting Highlights: Alphabet (NASDAQ:GOOGL) was the largest company…
Credit Suisse Maintains Neutral on Verisk Analytics, Raises Price Target to $155
Credit Suisse maintains Verisk Analytics (NASDAQ:VRSK) with a Neutral and raises the price target from $150 to $155.